Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.005 USD | -2.82% | -2.25% | +10.73% |
May. 09 | Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M | MT |
May. 09 | Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 47.06M | Sales 2025 * | 138M | Capitalization | 98.25M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | 11M | EV / Sales 2024 * | 2.09 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
-5.58
x | P/E ratio 2025 * |
10.7
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 41.41% |
Latest transcript on ProPhase Labs, Inc.
1 day | +3.41% | ||
1 week | +1.98% | ||
1 month | -3.01% | ||
3 months | +12.94% | ||
6 months | +3.73% | ||
Current year | +13.94% |
Managers | Title | Age | Since |
---|---|---|---|
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Chief Operating Officer | 50 | Dec. 31 | |
Robert Morse
AUD | Comptroller/Controller/Auditor | 49 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Gleckel
BRD | Director/Board Member | 68 | 09-05-31 |
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Jason Barr
BRD | Director/Board Member | 44 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 25 M€ | -2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 5.005 | -2.82% | 12 643 |
24-05-31 | 5.15 | +4.25% | 27,305 |
24-05-30 | 4.94 | -4.08% | 84,329 |
24-05-29 | 5.15 | +0.59% | 50,377 |
24-05-28 | 5.12 | +1.39% | 39,235 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.94% | 98.25M | |
-24.66% | 7.76B | |
+68.65% | 4.33B | |
-2.98% | 2.64B | |
+3.57% | 2.63B | |
-46.17% | 2.16B | |
-15.27% | 1.75B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- PRPH Stock